Soongyu Choi

USPTO Granted Patents = 24 (Patent Applications = 3)

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 8 (Patent Applications = 2)

Average Co-Inventor Count = 8.8

ph-index = 10

Forward Citations = 216(Granted Patents)

Location History:

Trumbull, CT (US) (2004 - 2005)
Skillman, NJ (US) (2006 - 2016)
New York, NY (US) (2019)
Princeton, NJ (US) (2020)
Belle Mead, NJ (US) (2016 - 2023)

Company Filing History:

17 out of 183

Ptc Therapeutics, Inc.

patents

7 out of 168

F. Hoffmann-la Roche Ag

patents

5 out of 70

Bayer Pharmaceuticals Corporation

where one patent can have more than one assignee

Years Active: 2004-2023

Loading Chart...

24 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11753407 - Compounds for treating spinal muscular atrophy (2023-09-12),

2. 10851101 - Compounds for treating spinal muscular atrophy (2020-12-01),

3. 10584115 - Substituted pyridine and pyrazine BMI-1 inhibitors (2020-03-10),

4. RE47689 - Compounds for treating spinal muscular atrophy (2019-11-04),

5. 9879007 - Compounds for treating spinal muscular atrophy (2018-01-30),

6. 9617268 - Compounds for treating spinal muscular atrophy (2017-04-11),

7. 9586955 - Compounds for treating spinal muscular atrophy (2017-03-07),

8. 9371336 - Compounds for treating spinal muscular atrophy (2016-06-21),

9. 9351964 - Methods for treating cancer and non-neoplastic conditions (2016-05-31),

10. 9271960 - Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control (2016-03-01),

11. 8946444 - Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control (2015-02-03),

12. 8940896 - Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis (2015-01-27),

13. 8372860 - Carboline derivatives useful in the inhibition of angiogenesis (2013-02-12),

14. 8367694 - Carboline derivatives useful in the inhibition of angiogenesis (2013-02-05),

15. 8143257 - Substituted phenols as active agents inhibiting VEGF production (2012-03-27),

Title: The Innovation Journey of Inventor Soongyu Choi

Introduction:

Inventor Soongyu Choi, based in Skillman, NJ (US), is a prolific innovator with a strong focus on healthcare and biotechnology. With an impressive portfolio of 24 patents, Choi has made significant contributions to the field of molecular compounds and treatments for complex diseases.

Latest Patents:

Choi's latest patents focus on compounds for treating spinal muscular atrophy, showcasing his dedication to developing novel solutions for critical medical conditions. These compounds, outlined in Formula (I), offer promising avenues for addressing spinal muscular atrophy and improving patient outcomes.

Career Highlights:

Throughout his career, Choi has made valuable contributions to renowned companies in the pharmaceutical and biotech industries. He has worked at Ptc Therapeutics, Inc. and F. Hoffmann-La Roche AG, where he has played a key role in advancing research and development initiatives.

Collaborations:

Choi has collaborated closely with esteemed professionals in the field, including coworkers such as Hongyan Qi and Young-Choon Moon. These collaborations have fostered creative synergies, leading to groundbreaking discoveries and innovative solutions in the healthcare arena.

Conclusion:

In conclusion, Soongyu Choi stands as a beacon of innovation in the realm of biotechnology and healthcare. His relentless pursuit of novel compounds for treating spinal muscular atrophy exemplifies his commitment to making a positive impact on patient care. With a rich tapestry of patents and collaborations, Choi continues to push the boundaries of scientific discovery, shaping the future of healthcare innovation.

This text is generated by artificial intelligence and may not be accurate.